Eva Venegas-Moreno Selected Research

Eva Venegas-Moreno Research Topics

Disease

16	Pituitary Neoplasms (Pituitary Adenoma) 01/2022 - 02/2014
11	Neoplasms (Cancer) 01/2022 - 03/2015
6	Acromegaly 04/2019 - 09/2010
5	Prolactinoma (Prolactinomas) 01/2021 - 01/2019
3	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2022 - 01/2020
2	Adenoma (Adenomas) 01/2017 - 11/2015
1	Vitamin B 12 Deficiency (Vitamin B12 Deficiency) 03/2022
1	Dyslipidemias (Dyslipidemia) 03/2022
1	Hypertriglyceridemia 03/2022
1	Obesity 03/2022
1	Type 2 Diabetes Mellitus (MODY) 03/2022
1	Hypertension (High Blood Pressure) 03/2022
1	Craniopharyngioma (Craniopharyngiomas) 01/2022
1	Hypogonadism (Hypergonadotropic Hypogonadism) 10/2021
1	Osteoporosis 10/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Sepsis (Septicemia) 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Hyperlipidemias (Hyperlipidemia) 01/2020
1	Tachycardia (Tachyarrhythmias) 10/2019
1	Hyperthyroidism 10/2019
1	Headache (Headaches) 10/2019
1	Vision Disorders (Hemeralopia) 10/2019
1	Familial Isolated Pituitary Adenoma 04/2019
1	Rare Diseases (Rare Disease) 01/2019
1	Combined Pituitary Hormone Deficiency 01/2019
1	Pituitary ACTH Hypersecretion 02/2014
1	Neurocognitive Disorders (Clerambault Syndrome) 01/2013

Drug/Important Bio-Agent (IBA)

10	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2022 - 11/2015
6	Hormones (Hormone)IBA 01/2020 - 11/2015
5	Dopamine (Intropin)FDA LinkGeneric 01/2022 - 06/2016
5	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2022 - 06/2016
4	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2022 - 02/2014
4	Growth Hormone (Somatotropin)IBA 01/2019 - 01/2013
4	Insulin-Like PeptidesIBA 01/2019 - 01/2013
4	Insulin-Like Growth Factor I (IGF-1)IBA 01/2018 - 09/2010
3	GhrelinIBA 01/2022 - 03/2015
2	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2022 - 10/2021
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2015
2	ProlactinIBA 01/2022 - 01/2021
2	Peptides (Polypeptides)IBA 01/2020 - 03/2015
2	Octreotide (Sandostatin)FDA LinkGeneric 11/2016 - 04/2015
1	Vitamin D FDA LinkGeneric 03/2022
1	CholesterolIBA 03/2022
1	HDL CholesterolIBA 03/2022
1	CateninsIBA 01/2022
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2022
1	Estrogen ReceptorsIBA 01/2022
1	somatostatin receptor type 1IBA 01/2022
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2022
1	Temozolomide (Temodar)FDA LinkGeneric 01/2021
1	Dopamine Agonists (Dopamine Agonist)IBA 01/2021
1	Etoposide (VP 16)FDA LinkGeneric 01/2021
1	Dopamine Receptors (Dopamine Receptor)IBA 09/2020
1	Chromogranin AIBA 01/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 10/2019
1	Thyroxine (Levothyroxine)FDA LinkGeneric 10/2019
1	Phenformin (Fenformin)IBA 01/2019
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2019
1	BuforminIBA 01/2019
1	BiguanidesIBA 01/2019
1	pladienolide BIBA 01/2019
1	Metformin (Glucophage)FDA LinkGeneric 01/2019
1	Cadherins (E-Cadherin)IBA 01/2019
1	TBR-760IBA 01/2017
1	pasireotideIBA 11/2016
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 06/2016
1	Pituitary HormonesIBA 06/2016
1	Arginine Vasopressin (Argipressin)IBA 06/2016
1	Proteins (Proteins, Gene)FDA Link 04/2015
1	Messenger RNA (mRNA)IBA 04/2015
1	Ghrelin ReceptorsIBA 03/2015
1	Small Interfering RNA (siRNA)IBA 03/2015
1	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 02/2014

Therapy/Procedure

4	Therapeutics 04/2019 - 04/2015
2	Radiotherapy 01/2021 - 01/2019
1	Adjuvant Radiotherapy 01/2019
1	Operative Surgical Procedures 01/2019
1	Precision Medicine 06/2016